If you're a man in your 20s to 50s noticing lower energy, slower recovery from training, or other signs of declining testosterone, enclomiphene offers an oral route that encourages your body to produce more of its own testosterone instead of supplying it externally. Clinical data show it raises testosterone effectively while preserving fertility better than many replacement options. One consistent finding across studies is that it can lower IGF-1, a key substance produced by the liver. This isn't framed as a deal-breaker but as something you can anticipate and manage.
How Enclomiphene Works and Its IGF-1 Effect
Enclomiphene acts in the brain to block certain estrogen feedback signals. This leads to increased release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which then tell the testes to step up natural testosterone production. Human trials in men with secondary hypogonadism confirm solid testosterone increases.
At the same time, enclomiphene tends to reduce IGF-1 levels made in the liver. Researchers link this to its influence on estrogen-related pathways in liver tissue. In studies comparing it to topical testosterone, the IGF-1 drop was more pronounced with enclomiphene even as testosterone rose.
Physiology Made Simple
Picture your body's hormone signaling like a control system. Growth hormone from the pituitary reaches the liver and prompts IGF-1 production, which circulates to support muscle repair and other processes. Estrogen activity in the liver plays a supporting role in this. By modulating estrogen signals, enclomiphene can dial down IGF-1 output from the liver. It's a measurable shift seen in trial participants, but individual responses vary based on dose and baseline levels.
Addressing the IGF-1 Change Proactively
Lower IGF-1 from enclomiphene alone doesn't typically derail progress for most men, especially when testosterone is optimized. You can take direct steps to counter it. Sermorelin stimulates your pituitary to release more natural growth hormone in pulses that match your body's rhythm. This signals the liver to produce more IGF-1 through the normal pathway, helping restore balance.
Pairing the two lets you retain enclomiphene’s benefits—natural testosterone production without shutting down your system—while supporting IGF-1 for better day-to-day function.
Impact on Health Outcomes, Performance, and Response Speed
IGF-1 contributes to how quickly muscles repair after lifting, how your body handles training stress, and overall tissue maintenance. In men on enclomiphene, a noticeable drop might show up as modestly slower recovery between sessions or slightly reduced training adaptations if unaddressed. Studies note this dynamic, but adding a growth hormone stimulator like sermorelin has been shown to raise IGF-1 and support those processes.
This combination approach helps maintain consistent gym performance, faster bounce-back from workouts, and steadier results over months of use compared to enclomiphene by itself.
Practical Steps for Men Considering Enclomiphene
Get baseline bloodwork that includes testosterone, LH/FSH, and IGF-1 before starting. Regular follow-ups let you adjust as needed. Many men in this age range find enclomiphene works well as a first-line option versus direct replacement, with the flexibility to layer in sermorelin or another growth hormone secretagogue to support stable or improved growth hormone levels. Talk to a provider familiar with both to build a plan that fits your labs and goals.
For tailored hormone management including enclomiphene or peptide options like sermorelin, services such as those at Vita Bella connect men with providers who handle these specifics.
This setup makes it straightforward to monitor and fine-tune treatment without unnecessary complications.
References
Wiehle RD, Fontenot GK, Wike J, et al. Testosterone restoration using enclomiphene citrate in men with secondary hypogonadism: a pharmacodynamic and pharmacokinetic study. BJU Int. 2013;112(6):E384-E392. doi:10.1111/bju.12363.
Helo S, Mahon J, Ellen J, et al. Serum levels of enclomiphene and growth hormone releasing peptide treatment in men. J Urol. 2016;195(4S):e1013. (Abstract).
Sinha DK, Maiti K, Bhattacharyya S. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Transl Androl Urol. 2020;9(Suppl 2):S215-S225.
